ENT Devices Market Report: By Product Type (Diagnostic Devices, Surgical Devices, Hearing Aids, Visualization Devices), End User (Hospitals, ENT Clinics, Ambulatory Centers) – Global Industry Size, Share and Growth Forecast to 2030

Market Overview

The global ENT devices market accounted for a revenue of $17,439.8 million in 2021, and it is expected to reach $31,805.3 million by 2030, advancing at a CAGR of 6.9% during 2021–2030. The proliferating incidence of hearing disorders and sinusitis, growing preference for minimally invasive procedures in ENT specialty, and increasing healthcare expenditure are boosting the market growth. The growing aging population also supports the demand for ENT devices, as the geriatric population is more prone to hearing loss and disorders associated with throat and nose. As per the WHO statistics, the number of geriatric people is set to grow by over 15% by 2050.

Some of the other factors driving the market for ENT devices include the technological advancements leading to their advanced applications, surging cases of chronic ear infection, growing life expectancy, and increasing noise pollution. Hearing impairment is one of the most common factors in patients, especially in industrialized countries. Infections such as middle ear infection, measles, and meningitis are also some common factors causing hearing loss in developing economies. In addition, chronic inflammation, vascular disorders, noise exposure, genetic susceptibility, and physiological aging of the ear may cause hearing impairment.

Furthermore, as many medical insurance players do not cover cosmetic ENT procedures, the need for cosmetic ENT procedures, including otoplasty (ear reshaping) and rhinoplasty (nose reshaping), is surging. Less invasive procedures; increased safety, popularity, and accessibility of cosmetic ENT procedures; and rise in disposable income of people are other key factors inspiring people to spend more on these procedures.

Moreover, the healthcare system has witnessed a paradigm shift from conventional surgeries to minimally invasive procedures over the past few years. The minimally invasive procedures have become popular in a variety of specialties, including oncology, gastroenterology, and urology. Similarly, in the ENT specialty, the preference for minimally invasive procedures has been steadily increasing.

The outbreak of the COVID-19 pandemic majorly affected the availability of hospital resources globally. This led to the reduction in accessibility to inpatient and outpatient services for other diseases, as well as the implementation of infection prevention and control measures. With the pandemic affecting countries all over the world, the number of ENT disease screening and diagnostic procedures declined and affected the ENT devices market growth.

Aging Population Drives the Demand for ENT Products

In 2021, diagnostic devices accounted for the largest share, of around 44.1%, in the market. This is due to the availability of several products, entry of new players, rise in the elderly population, and surge in the incidence of various ENT disorders. Moreover, the new product launch is further projected to propel the market growth in this category.

Furthermore, hearing aids are the second-largest used product in the market. This is because manufacturers are more focused on launching advanced hearing aids to improve their market presence. For Instance, in February 2022, Oticon A/S launched Oticon Zircon. This product provides new features like users to handle multiple, dynamic sounds from all directions and 360° speech that is clear and balanced even in noisy situations.

Further, surgical devices are the third-largest used product in the market. This is due to the global companies such as Boston Scientific Corporation, Medtronic plc, Smith & Nephew Plc, Olympus Corporation, Johnson & Johnson, and Atos Medical Ab providing surgical devices. The companies are offering an elaborate product portfolio, including capital equipment and other surgical devices used during ENT procedures. The presence of various companies assists in increasing technology integration in surgical devices.

Growing Prevalence of ENT Diseases

There is a surging prevalence of ENT diseases across the world, with the rise in non-communicable illnesses, including ENT disorders, which are caused due to the little attention provided to these diseases at the global health level. The most widespread complaint experienced among the population is infections in the ear, nose, and throat. The frequent infection forces people to get antibiotics prescribed by doctors, and most of them visited hospitals due to ENT problems.

Sinusitis is the most common medical condition experienced, which is caused by the common cold. The most common symptom of the disease is a stuffy and blocked nose, which may prevent drainage of mucus and block the sinuses. Chronic sinusitis is a major factor leading to a large number of surgeries performed in the U.S. every year and affects around 10% of adult populations. Thus, this reason drives the ENT devices market growth.

Explore more about this report - Request free sample pages

Hospitals Captured Majority of Market Share

In 2021, the hospitals category accounted for over 42% of revenue share in the market. Hospitals are the major treatment facilities in the global healthcare system. In the ENT specialty, hospitals play a critical role in care delivery. Often in emerging economies, the hospitals are the sole facilities for performing ENT surgical procedures. Moreover, the rising disposable income, decreasing cost of ENT treatment, improving healthcare infrastructure and spending, and increasing knowledge and awareness about ENT procedures across the world are the key factors driving the market.

Furthermore, ENT clinics are the second-largest end users of ENT devices in the market. This is because clinics are often the sites for diagnosis of ear, nose, and throat diseases, with limited treatment facilities. Often in emerging economies, ENT clinics are primarily comprising hearing diagnostic devices, such as audiometers, tympanometers, and hearing screening systems.

North America Generates the Highest Demand for ENT Devices

North America led the market, with a revenue share of 32.8%, in 2021. This is attributed primarily to the improving reimbursement scenario for ENT procedures and the presence of strong market players in this region. In addition, the growing awareness about the benefits of ENT devices leads to the increased acceptance of these devices in the region.

Whereas, the APAC market is expected to grow at a high growth rate, where China and India are major markets in the region. The key growth driving forces for the regional market include the presence of a high patient pool with sinusitis, the increase in awareness of these devices, and the rise in the elderly population.

Key Players Are Involved in Product Launches to Gain Significant Position

Key players operating in the ENT devices market have been actively engaged in product launches, in order to strengthen their product portfolios and achieve a larger market share. For instance:

• In February 2022, Oticon A/S launched the artificial deep neural network (DNN) technology-based Oticon More hearing aid for children, and the discreet behind-the-ear (BTE) style hearing aids.
• In May 2021, Bose Corporation launched new SoundControl Hearing Aids, which is available in Massachusetts, Montana, North Carolina, South Carolina, and Texas.

Key Players in ENT Devices Market Are:

• Boston Scientific Corporation
• Karl Storz Gmbh & Co. KG
• Oticon A/S
• Medtronic plc
• Stryker Corporation
• Smith & Nephew plc
• Olympus Corporation
• Hoya Corporation
• Widex A/S

Market Size Breakdown by Segment

The report offers comprehensive market segmentation analysis along with market estimation for the period 2017–2030.

Based on Product Type

• Diagnostic Devices
• Surgical Devices
• Hearing Aids
• Visualization Devices

Based on End User

• Hospitals
• ENT Clinics
• Ambulatory Centers

Geographical Analysis

• North
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • Saudi Arabia
  • South Africa